A transgene, alv6, that expresses the envelope of subgroup A avian leukosis virus reduces the rate of congenital transmission of a field strain of avian leukosis virus.
A major mode of transmission of avian leukosis virus (ALV) is from a dam that is viremic with and immunologically tolerant to ALV, through the egg to the progeny. The authors have produced a line of chickens transgenic for a defective ALV provirus that expresses envelope glycoprotein, but not infectious virus, and is very resistant to infection with Subgroup A ALV. In the present experiment the authors sought to prevent or reduce congenital transmission by mating viremic-tolerant hens to males carrying the inserted provirus, thus introducing a gene for resistance into the progeny. Mature viremic females were mated with males hemizygous for the transgene to produce over 80 progeny each with and without the transgene. The chicks were hatched and maintained for 36 wk and observed for viremia, antibody, and the incidence of bursal lymphomas. Over 90% of the transgene-negative controls remained viremic through 36 wk of age and 51% developed bursal lymphomas. In contrast, 27% of the transgene-positive birds remained viremic and 18% died with bursal lymphomas. Thus, expression of Subgroup A envelope protein in the developing embryo reduced but did not eliminate congenital infection.
Crittenden
L B
LB
USDA Agricultural Research Service, Avian Disease and Oncology Laboratory, East Lansing, Michigan 48823.
Salter
D W
DW
D000704:Analysis of Variance; D000818:Animals; D030801:Animals, Genetically Modified; D000914:Antibodies, Viral / Q000097:blood; D001353:Avian Leukosis / Q000151:congenital / Q000235:genetics / Q000517:prevention & control*; D001354:Avian Leukosis Virus / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification; D002645:Chickens; D005260:Female; D008297:Male; D014766:Viremia / Q000235:genetics / Q000517:prevention & control*
D000914:Antibodies, Viral